TCL Archive Avastin-Zybrestat Combination Increases Progression-Free Survival in Phase II Trial March 28, 2014
TCL Archive ASCO Urges NCI To Spell Out Metrics of Success Beyond Cutting Groups to Arbitrary Number June 17, 2011
TCL Archive Two Conflicting Studies Presented at ASCO 2013, FDA Called Upon To Sort Through The Data June 28, 2013
TCL Archive Schmidt’s Advice To Upton: Take A Look At grants Vs. Contracts, Carcinogenesis, Cancer Control July 1, 1977
TCL Archive Drug Discover Groups Recompetition Approved, But Advisors Scale Back Model Development March 15, 1991
